WallStreetZenWallStreetZen

NASDAQ: CDMO
Avid Bioservices Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CDMO past revenue growth

How has CDMO's revenue growth performed historically?
Company
5.03%
Industry
149.51%
Market
17.15%
CDMO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CDMO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CDMO's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CDMO earnings and revenue history

Current Revenue
$140.9M
Current Earnings
-$11.5M
Current Profit Margin
-8.1%

CDMO Return on Equity

Current Company
-6.1%
Current Industry
15.4%
Current Market
-8.4%
CDMO's Return on Equity (-6.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CDMO announces earnings.

CDMO Return on Assets

Current Company
-2.5%
Current Industry
2.2%
CDMO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CDMO Return on Capital Employed

Current Company
-2.28%
Current Industry
17.7%
CDMO's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CDMO vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CDMO$140.94M$604.00k-$11.45M+31.00%N/A
LXRX$1.20M-$163.46M-$177.12M-54.71%N/A
VYGR$250.01M$126.46M$132.33M+101.01%+128.28%
TRDA$129.01M$14.90M-$6.69MN/AN/A
ANNX$0.00-$130.97M-$134.24MN/AN/A
View Top Biotech Stocks

CDMO earnings dates

Next earnings date
Jun 19, 2024

Avid Bioservices Earnings & Revenue FAQ

What were CDMO's earnings last quarter?

On Invalid Date, Avid Bioservices (NASDAQ: CDMO) reported Q3 2023 earnings per share (EPS) of -$0.15, up 650% year over year. Total Avid Bioservices earnings for the quarter were -$9.51 million. In the same quarter last year, Avid Bioservices's earnings per share (EPS) was -$0.02.

If you're new to stock investing, here's how to buy Avid Bioservices stock.

What was CDMO's earnings growth in the past year?

As of Q2 2024, Avid Bioservices's earnings has grown year over year. Avid Bioservices's earnings in the past year totalled -$11.45 million.

What is CDMO's earnings date?

Avid Bioservices's earnings date is Invalid Date. Add CDMO to your watchlist to be reminded of CDMO's next earnings announcement.

What was CDMO's revenue last quarter?

On Invalid Date, Avid Bioservices (NASDAQ: CDMO) reported Q3 2023 revenue of $25.40 million up 26.94% year over year. In the same quarter last year, Avid Bioservices's revenue was $34.76 million.

What was CDMO's revenue growth in the past year?

As of Q2 2024, Avid Bioservices's revenue has grown 5.03% year over year. This is 144.48 percentage points lower than the US Biotechnology industry revenue growth rate of 149.51%. Avid Bioservices's revenue in the past year totalled $140.94 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.